19 results
management differential lupus treatment erythematosus sle activetb algorithm antinuclear disease druginduced hematology latenttb table tb tuberculosis vasculitis antibodies arteritis arthritis
Differential Diagnosis of Hypoglycemia Evaluation of Hypoglycemia Patients with known diabetes who are not systemically ill and can
of Hypoglycemia Evaluation ... #EM #IM #Hypoglycemia ... Differential #Algorithm #Drugs ... #Malignancy #Exogenous ... #Hypoglycemic #Ddxof
Algorithm for the Evaluation and Management of Sickle Cell Crises Clinical Manifestations and Management #Diagnosis #Management #Hematology #SickleCell
Algorithm for the Evaluation ... Sickle Cell Crises Clinical ... Management #Diagnosis ... Manifestations #Workup ... #Algorithm #Ddxof
Antinuclear Antibodies (ANA) ANA or Anti-NucIear Antibody refers to antibodies against antigens in the nucleus → like
) ANA or Anti-NucIear ... likely it will be clinically ... Non-Rheumatic Diseases: Malignancy ... #patterns #rheumatology ... #diagnosis #differential
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
(SLE) - Diagnosis ... 40, F:M 9:1 • Clinical ... • Immunologic Workup ... : - ANA > ... Management #Summary #rheumatology
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
: - ANA > ... months to years) Systemic ... : - ANA > ... comparison #table #rheumatology ... #diagnosis #management
IgG4-Related Disease Clinical history: Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor 4 phenotypes: •
Related Disease Clinical ... aorta • Head ... female, asian • Systemic ... management #phenotypes #workup ... #treatment #rheumatology
Vasculitis and Vasculitides - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions •
- Differential Diagnosis ... < 30 years - Aorta ... • GCA: - Aorta ... LFT • ESR • ANA ... #rheumatology #
Antinuclear antibodies and Systemic lupus Anti-dsDNA 60-80% Association with disease activity (when with Farr assay) and lupus nephritis. Can
searched for when ANA ... SLE (60-70%) & drug-induced ... -15% If SLE is clinically ... #rheumatology # ... table #ANA
SLE (Systemic Lupus Erythematosus) Suspect: Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... findings (ANA, ... Serositis Labs: • ANA ... antibodies • (-) ANA ... #Rheumatology
Cryptogenic Organizing Pneumonia (COP) Cryptogenic Organizing Pneumonia Overview: • Idiopathic form of organizing pneumonia • formerly BOOP
association with CTD, drugs ... , malignancy and ... Organizing Pneumonia - Clinical ... other processes Workup ... : ANA, RF, CCP,
No results found for "ddxof evaluation aorta aaa em malignancy clinical drugs diagnosis rheumatology ana workup systemic"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ddxof #evaluation #aorta #aaa #em #malignancy #clinical #drugs #diagnosis #rheumatology #ana #workup #systemic